Assert-IQ vs Cardiac Guidance

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Assert-IQ

by Abbott

Cardiac Guidance

by Caption Health

AI Verdict

Assert-IQ focuses on long-term, continuous monitoring of heart rhythms using an insertable cardiac monitor to detect and manage arrhythmias. In contrast, Cardiac Guidance provides AI-guided assistance for real-time acquisition and interpretation of diagnostic-quality cardiac ultrasound images. While both are cardiology AI tools, they address distinct diagnostic needs: one for rhythm disorders and the other for structural and functional cardiac imaging.

Choose Assert-IQ if…

Choose Assert-IQ if your primary need is long-term, continuous monitoring for comprehensive arrhythmia detection in patients with suspected heart rhythm disorders. This tool is ideal for identifying infrequent or asymptomatic arrhythmias over an extended period, providing detailed data for diagnosis and ongoing management through remote monitoring and proactive alerts.

View Assert-IQ →

Choose Cardiac Guidance if…

Choose Cardiac Guidance if you need to empower healthcare professionals, including those without extensive ultrasound expertise, to acquire and interpret diagnostic-quality cardiac ultrasound images rapidly at the point of care. This solution is best suited for democratizing access to critical cardiac assessments in settings like emergency departments or clinics where immediate, guided cardiac imaging is crucial for early disease detection and accessible care.

View Cardiac Guidance →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Assert-IQ	Cardiac Guidance
Deployment	Subcutaneously implanted device with mobile app connectivity	Caption Guidance is deployed in acute point-of-care settings, including emergency and anesthesiology departments and critical care units. It is also used in doctors' offices and can be used for at-home care.
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardiac Guidance

Cardiac Guidance (Tool B) explicitly focuses on simplifying a complex diagnostic procedure, offering 'real-time AI guidance' and 'turn-by-turn on-screen probe movement instructions' designed for 'non-expert ultrasound users'. This significantly lowers the barrier to entry for acquiring diagnostic-quality cardiac ultrasound images, making it highly usable for a broader range of healthcare professionals. Assert-IQ (Tool A), while minimally invasive, primarily involves passive monitoring and patient symptom logging, which is less about simplifying a complex clinical skill.

Clinical Value

Cardiac Guidance

Cardiac Guidance (Tool B) offers substantial clinical value by 'democratizing access to critical cardiac assessments' through AI-guided ultrasound, enabling early disease detection at the point of care. Its ability to empower non-expert users to acquire and interpret diagnostic-quality images, including automated EF calculation, can significantly expand access to essential cardiac diagnostics. Assert-IQ (Tool A) provides excellent long-term, continuous monitoring for arrhythmia detection, which is crucial for specific patient populations, but Tool B's potential to broaden diagnostic capabilities to new settings and users gives it an edge in overall clinical impact.

Pricing & Value

Tie

Both Assert-IQ (Tool A) and Cardiac Guidance (Tool B) require direct contact with the vendor for pricing details, and neither offers a free trial. Without transparent pricing information or specific case studies demonstrating cost-effectiveness, it is impossible to definitively compare their value propositions. Therefore, a tie is appropriate for this dimension.

Enterprise Readiness

Assert-IQ

Assert-IQ (Tool A) explicitly targets 'Large health systems, hospitals, cardiology clinics' and offers 'hybrid' deployment and 'data export' capabilities, indicating a robust design for enterprise integration. It is also FDA cleared and HIPAA compliant. While Cardiac Guidance (Tool B) is also FDA cleared and HIPAA compliant, its deployment as a 'Software accessory integrated with compatible general purpose diagnostic ultrasound systems' suggests a more specialized integration pathway compared to Tool A's broader enterprise focus.

Innovation

Cardiac Guidance

Cardiac Guidance (Tool B) demonstrates higher innovation by fundamentally changing how cardiac ultrasound can be performed, enabling 'real-time AI guidance' and 'turn-by-turn on-screen probe movement instructions' for non-expert users. This approach 'democratizes access' to a complex diagnostic procedure, representing a significant shift in clinical practice. Assert-IQ (Tool A) offers advanced algorithms and remote capabilities for an insertable cardiac monitor, which are enhancements to existing technology rather than a disruptive change in diagnostic methodology.

Support & Docs

Tie

Both Abbott Medical (for Assert-IQ) and Caption Health (for Cardiac Guidance) provide professional resources, manuals, and technical support for their products. However, the provided structured facts and general web searches do not offer sufficient comparative detail regarding the depth, accessibility, or quality of their respective support and documentation offerings. Therefore, based on the available information, it is not possible to distinguish a clear winner, resulting in a tie.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Assert-IQ	Cardiac Guidance
Name	Assert-IQ	Cardiac Guidance
Company	Abbott Medical	Caption Health
Mobile App	none	Not specified
Key Functionality	Long-term continuous cardiac monitoring and advanced arrhythmia detection.	AI-guided cardiac ultrasound image acquisition and interpretation, including automated left ventricular ejection fraction (EF) calculation.
Target User/Setting	Large health systems, hospitals, cardiology clinics	Healthcare professionals (including non-expert ultrasound users) at the point of care.
Specialties	Cardiology, Internal Medicine	Cardiology, Emergency Medicine, Radiology

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and Cardiac Guidance.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical purpose of each tool?

Assert-IQ is designed for long-term, continuous cardiac monitoring to detect and manage patients with suspected heart rhythm disorders, offering up to six years of monitoring. Cardiac Guidance is an AI tool that helps healthcare professionals acquire and interpret diagnostic-quality cardiac ultrasound images at the point of care, democratizing access to critical cardiac assessments.

What level of user expertise is required for each tool?

Assert-IQ is utilized by physicians in specialties like Cardiology and Internal Medicine for managing arrhythmia patients. Cardiac Guidance is designed to empower a broader range of healthcare professionals, including non-expert ultrasound users, to acquire and interpret diagnostic-quality cardiac ultrasound images with AI guidance.

What specific diagnostic insights or data does each tool provide?

Assert-IQ provides long-term continuous cardiac monitoring data with advanced arrhythmia detection algorithms and proactive clinician alerts. Cardiac Guidance offers real-time AI guidance for cardiac ultrasound image acquisition, automated quality assessment, auto-capture of images and video clips, and automated left ventricular ejection fraction (EF) calculation.

Can these tools be integrated with existing hospital systems or devices?

Assert-IQ utilizes a secure cloud-based data platform for remote monitoring capabilities. Cardiac Guidance is deployed as a software accessory that integrates with compatible general-purpose diagnostic ultrasound systems, such as the GE HealthCare Venue Family or Vscan Air SL, allowing use with existing equipment.

What is the duration of monitoring or assessment offered by each tool?

Assert-IQ provides long-term continuous cardiac monitoring for an extended period, with options for battery life of at least three or six years. Cardiac Guidance facilitates point-of-care cardiac assessments, offering real-time guidance and automated analysis for immediate diagnostic-quality ultrasound imaging.